Everything we claim, documented.
The mechanism, the trial data, and the peer-reviewed study behind GLP-1 Biotic Matrix. Written for the curious, with the science intact.
First, what GLP-1 actually does
GLP-1 (glucagon-like peptide-1) is an incretin hormone secreted by intestinal L-cells in response to nutrient intake. It is your body's own post-meal satiety and glucose-regulating signal, acting on four fronts:
Suppresses appetite
Signals the hypothalamus to reduce hunger and food intake (central satiety).
Regulates glucose
Potentiates glucose-dependent insulin secretion, attenuating postprandial spikes.
Slows gastric emptying
Delays nutrient transit, prolonging satiety after a single meal.
Mobilizes fat
Supports lipolysis in white adipose tissue, releasing stored triglycerides.
GLP-1 receptor agonist drugs (semaglutide, tirzepatide) deliver a synthetic analog of this hormone by injection. GLP-1 Biotic Matrix takes the opposite approach: stimulating endogenous (your body's own) GLP-1 secretion via the gut.
The mechanism, step by step
Substrates reach the distal gut
One serving delivers a heat-treated postbiotic, fermentable prebiotics, and apple polyphenols to the lower intestine.
Fermentation yields SCFAs
Gut microbiota ferment the substrates into short-chain fatty acids (acetate, propionate, butyrate), the endogenous trigger for incretin release.
L-cells are activated
SCFAs bind free fatty-acid receptors (FFAR2/3) on enteroendocrine L-cells, the cells that synthesize GLP-1 and its partner peptide PYY.
Endogenous GLP-1 is secreted
In vitro, the formula raised GLP-1 secretion by 51.8% and expression of the appetite-suppressing gene PYY by 79.8%.
Central satiety, peripheral glucose control
Circulating GLP-1 signals satiety while gastric emptying slows; postprandial glucose excursion is attenuated. Fullness holds 4 to 6 hours.
The loop is reinforced daily
Continued substrate feeding sustains microbial SCFA production, maintaining endogenous secretion over time.
A randomized, controlled, crossover design
Each subject served as their own control, tested on two visits (water vs. formula) 30 minutes before a 75 g oral glucose load, with plasma sampled across 270 minutes.
Plasma GLP-1 response
Fold-change vs. fasting baseline.
Endpoints: +16% at 30 min pre-load; 3.8x at 75 min; 4.7x at 90 min vs. water control.
Postprandial glucose, mg/dL
75 g glucose administered at minute 30.
Glucose excursion vs. control: 8.0% lower at 60 min; 5.0% at 75 min; 9.7% at 90 min.
Subjects also reported lower postprandial hunger and craving scores in the formula condition, consistent with the hormonal response.
The 560-subject cohort study
A real-world study of overweight and obese adults using the formula daily, peer-reviewed and published in 2024.
Mean reduction of 4.9 kg (10.8 lbs) over two months, with no adverse events reported.
Equivalent to an approximate weekly energy deficit of 4,725 kcal, achieved without digestive distress or reported side effects.
Chi-Fu C, Yung-Hsiang L, Chen-Chen F, et al. Efficacy of GLP-1 formula on body weight in overweight and obese adults. Acta Scientific Medical Sciences. 2024;8(10):62-67.
Gene-expression shifts from storage to oxidation
In cell-model testing, the formula up-regulates fat-oxidation pathways and down-regulates lipid-storage regulators. Measured change in relative gene expression:
Significance vs. untreated control: *p<0.05, **p<0.01, ***p<0.001. In-vitro findings describe mechanism and do not by themselves predict human outcomes; see human data above.
The actives, and the science behind each
A bio-synergetic system: a postbiotic, fermentable prebiotics, and a polyphenol-rich plant extract.
Bifidobacterium breve TC1761 (postbiotic)
Bifidobacterium breve TC1761 (postbiotic)A heat-treated, shelf-stable postbiotic. Its cell fragments and metabolites interact with the intestinal epithelium to stimulate L-cell incretin output. In vitro: +51.8% GLP-1 secretion, +79.8% PYY expression.
Kombucha black tea + hydrolyzed soy protein (prebiotics)
Kombucha black tea + hydrolyzed soy protein (prebiotics)Rapidly fermentable substrates that drive microbial production of short-chain fatty acids (acetate, propionate, butyrate), the FFAR2/3 ligands that trigger endogenous GLP-1 release.
Rockit™ apple fruit extract (polyphenols)
Rockit™ apple fruit extract (polyphenols)Rich in phloridzin and procyanidins. Acts as a natural alpha-glucosidase inhibitor (slowing carbohydrate absorption), directly stimulates GLP-1 release, and up-regulates fat-oxidation genes in adipose tissue.
Gum acacia, erythritol, indigestible maltodextrin (fiber)
Gum acacia, erythritol, indigestible maltodextrin (fiber)Soluble-fiber carriers and osmolytes that mechanically delay gastric emptying, prolonging postprandial satiety.
Made to clinical standards
Where the research goes next
Acute GLP-1 response
IRB-approved crossover study, 25 subjects. Publication submitted.
Glycemic control
Randomized, double-blind, placebo-controlled, 100 subjects.
Weight management
Randomized, double-blind, placebo-controlled, 300 subjects.
"We did not set out to mimic the drug. We set out to make the gut do what it already knows how to do, and then measure it honestly."
References
- 1. Chi-Fu C, Yung-Hsiang L, Chen-Chen F, et al. Efficacy of GLP-1 formula on body weight in overweight and obese adults. Acta Scientific Medical Sciences. 2024;8(10):62-67.
- 2. GLP-1 Formula IRB human study: instant GLP-1 boosting. Clinical Trial & Claim Lab (C&C Lab), 2026. Acute crossover response, n=25.
- 3. In-vitro evaluation of GLP-1, PYY, UCP1/2, ATGL, GLUT4, PLIN1 and PPARG2 expression in colonic and adipocyte cell models.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare practitioner before use if pregnant, nursing, taking medication, or managing a medical condition.
The science is published. The jelly is ready.
One stick a day, 30 minutes before your largest meal.
Shop GLP-1 Biotic Matrix